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We studied the antioxidative role of melatonin against benzene toxicity in rat liver. The inhibition of 
mitochondrial and microsomal lipid peroxidation differed between 24-hour (single-dose), 15-day, and 
30-day treatments. Inhibition of mitochondrial lipid peroxidation was the highest after the single dose 
of melatonin, whereas highest microsomal inhibition was recorded after 30 days of melatonin treatment. 





2E1) activity declined after the single-dose and 15-day melatonin treatment in the benzene-
treated group, but it rose again, though not signiﬁ cantly after 30 days of treatment. Liver histopathology 
generally supported these ﬁ ndings. Phenol concentration in the urine samples declined in melatonin and 
benzene-treated rats. Our results show that melatonin affects CYP
450
2E1, which is responsible for benzene 
metabolism. Inhibition of its metabolism correlated with lower lipid peroxidation. In conclusion, melatonin 
was found to be protective against lipid peroxidation induced by benzene.
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Benzene has widely been used as a general purpose 
industrial solvent. However, it is now used principally 
as an intermediate in the synthesis of other chemicals. 
Epidemiological studies have linked occupational 
exposure to benzene with a variety of leukaemias in 
humans (1). It has been established that benzene needs 





2E1) to manifest its cytotoxic and genotoxic 
effects (2-4). Subsequent secondary activation of its 
metabolites by myeloperoxidase (MPO) present in the 
bone marrow results in the production of xenotoxic 
quinines and reactive oxygen species (ROS). The latter 
account for most of benzene toxicity (5).
Melatonin (N-acetyl-5-methoxytryptamine) has 
for long been associated with circadian rhythm. 
Recently however, Reiter (6) described an intriguing 
antioxidant property of melatonin. It protected against 
free radical-induced damage in rat liver by maintaining 
or increasing the activity of antioxidant enzymes 
such as superoxide dismutase, catalase, glutathione 
peroxidase and glutathione reductase (7-9).
Melatonin eliminated hydroxyl radical, singlet 
oxygen, hydrogen peroxide, peroxyl radical, and 
hypochlorous acid through its direct scavenging action 
(10-14). It was found to protect against the toxicity 
of alpha-naphthylisothiocyanate (15), acetaminophen 
(16), irradiation (17), and arsenic (18). In addition 
to liver, beneﬁ cial effects of melatonin have been 
observed in the skin (19), cerebral ischaemia (20), 
and ocular diseases (21).
An earlier report from our laboratory (22) showed 
that lipid peroxidation induced by benzene in rat liver 
and kidney oscillated between circadian rhythms. 
We speculated this could be because of melatonin. 
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This study was therefore performed to establish 
the inﬂ uence of melatonin on lipid peroxidation in 
benzene-treated rats.
MATERIALS AND METHODS
Animals, benzene exposure, and melatonin 
treatment
Sixty three-month-old male Wistar rats were 
procured from the animal facility of Jamia Hamdard, 
New Delhi. They were maintained in the animal house 
of the Department under 12 h dark and light cycle. 
Each rat was offered pelleted food (Golden Feeds, 
New Delhi) and tap water ad libitum. Twenty male 
rats of equal, average body mass were selected for 
either of a 24-hour, 15-day, or 30-day experiment. 
The rats were further divided into four groups of ﬁ ve 
animals. Group A consisted of rats receiving benzene 
(CDH, Mumbai, India) alone. Group B consisted of 
rats receiving melatonin (Sigma Chemical Company, 
St. Louis, MO, USA) and benzene. Group C consisted 
of rats receiving melatonin alone. Group D were 
injected 0.2 mL olive oil (CDA, Mumbai, India) only 
and served as controls.
Benzene was administered to group A in the 
morning hours. Selection of dose was based on our 
previous studies on benzene toxicity, where the same 
dose and same method of administration were used 
(22). Rats received 0.20 mL of a benzene solution 
(2 % in olive oil) per 100 g of body mass. It was injected 
intramuscularly as a single dose, on each alternate day 
for 15 days, or on each alternate day for 30 days.
Melatonin was administered to group B at the dose 
of 10 mg kg-1 body mass 60 min before administration 
of benzene, which was administered at the rate 
described for group A. Group C received melatonin 
only in the same dose as the rats of group B. Melatonin 
was always administered in the morning hours.
The experimental protocol was approved by the 
Institutional Ethics Committee.
Tissue collection and sample preparation
Urine samples were collected from each rat 
through metabolic cages after 24 h, 15 days or 30 
days of melatonin and/or benzene treatment. They 
were kept frozen till analyses for phenol. Liver 
samples were collected from each rat after sacriﬁ ce, 
blotted dry with ﬁ lter paper and stored at -20 °C till 
analysis. The maximum storage time was one week. 
Ten-percent (w/v) homogenates were prepared using a 
Potter-Elvehjem homogenizer according to the method 
described for determination of malondialdehyde, 
reduced glutathione, and CYP
450
2E1 in liver samples 
(27).
Phenol
Phenol was estimated in the urine samples using 
the amino antipyrine method of Dannis (23). Pure 
liquid phenol and amino antipyrine were procured 
from CDH, Mumbai, India. The absorbance was 
recorded at 510 nm using a spectrophotometer 
(Systronics, Ahmedabad, India).
Lipid peroxidation
Lipid peroxidation in the liver was determined 
by measuring mitochondrial and microsomal 
malondialdehyde following the method of Jordan and 
Schanman (24). Microsomes were separated using 
an ultracentrifuge (Sorval, Newtown, CT, USA) 
following the method by Schenkman and Cinti (25). 
Thiobarbituric acid-reactive substances were measured 
at 532 nm using a spectrophotometer (Systronics, 
Ahmedabad, India). 1,1,3,3 tetramethoxypropane 
(Sigma, USA) was used as the standard. Thiobarbituric 
acid was purchased from Sigma, USA.
Reduced glutathione
Glutathione (GSH) was determined in the liver 
using the Ellman’s reagent [5,5’-dithiobis-(2-
nitrobenzoic acid), Sigma, USA]. Sulphosalicylic 
acid was used for protein precipitation. Absorbance 





CYP2E1 activity in microsomal preparations was 
estimated spectrophotometrically using the method 
of Koop (27). Brieﬂ y, the reaction mixture consisted 
of 0.2 g L-1 of microsomal protein, 0.1 mmol L-1 of 
potassium phosphate, pH 6.8, and of 1 mmol L-1 of 
p-nitrophenol. Samples were incubated at 37 °C for 
3 min prior to the addition of NADPH to start the 
reaction. After 10 min, the reaction was stopped with 
1.5 mol L-1 perchloric acid. Absorbance was measured 
at 510 nm. All these chemicals were procured from 
Sisco Research Laboratories, Mumbai, India.
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Protein measurements
Protein content in the liver samples was measured 
applying the method of Lowry et al. (28). Bovine 
serum albumin (BSA) was procured from Sigma, 
USA.
Histopathological observations
Small pieces of liver collected from the mid liver 
lobe of all treated and control rats were ﬁ xed in 10 % 
neutral formalin, dehydrated in graded ethanol, cleared 
in xylene, and embedded in parafﬁ n. Six-micrometer 
thick parafﬁ n sections thus prepared were stained 
with hematoxylin and eosin and examined under light 
microscope (Nikon, Tokyo, Japan). Formalin, ethyl 
alcohol, parafﬁ n, xylene, hematoxylin, and eosin 
were procured from Sisco Research Laboratories, 
Mombai, India.
Statistical analysis
The data were expressed as mean±SEM. Statistical 
evaluations were performed by the analysis of variance 
(ANOVA) (29). P<0.05 was considered as statistically 
signiﬁ cant.
RESULTS
Acute exposure to benzene signiﬁ cantly induced 
lipid mitochondrial and microsomal peroxidation in 
rat liver. GSH levels increased after acute treatment, 
but they dropped signiﬁ cantly after the 15-day and 
30-day exposure. CYP
450
2E1 activity increased after 
the single benzene dose (24 h), but decreased after 15 
days and 30 days (Table 1).
Melatonin pre-treatment inhibited mitochondrial 
and microsomal lipid peroxidation in the liver of 
benzene-treated rats (Table 1). GSH levels increased in 
the liver of melatonin and benzene-treated rats (Table 
1). CYP
450
2E1 activity ﬂ uctuated decreased after 24 h, 
further decreased after 15 days, but improved after 30 
days of melatonin administration to benzene-treated 
rats (Table 1). These observations are supported by the 
results on urinary phenol concentrations. It decreased 
after melatonin treatment for different durations 
(Figure 1).
No significant histopathological differences 
were observed between the groups of melatonin and 
benzene-treated rats. However, variation did occurr 
in rats treated with benzene alone. Benzene caused a 
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Results are expressed as mean±S.E. (n = 5)
* Denotes values signiﬁ cantly different from control rats
† Denotes values signiﬁ cantly different from benzene-treated rats
NS denotes non-signiﬁ cant differences
All values are signiﬁ cant at p<0.05
Values in parenthesis indicate the range.
MDA - malondialdehyde
GSH - glutathione
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massive necrosis in the rat liver (Figure 2). However, 
in melatonin and benzene-treated rats no centrilobular 
necrosis was recorded (Figure 3). Surprisingly, 
peripheral (focal) necrosis was observed in the liver 
of melatonin-treated rats (Figure 4).
at the site of production or in the liver (for circulating 
melatonin) through complex pathways. Thus through 
side chain changes melatonin can be transformed into 
5-methoxyindole acetic acid or 5-methoxytryptophol 
(34). Alternatively, by indoleamine 2,3-dioxygenase 
through the cleavage of the pyrrole ring, it can 
form N1-acetyl-N2 –formyl-5-methoxy-kynuramine 
(AFMK) (35). Reactive oxygen species are known 
to mediate in the oxidation of melatonin to AFMK. 
We believe that ROS may also cause focal necrosis 
in the liver.
Melatonin is well known to scavenge oxygen-
free radicals and to inhibit, in vitro and in vivo, lipid 
peroxidation generated by ethyl alcohol (36), carbon 
tetrachloride (37), and paraquat (38). This is the 
ﬁ rst report that shows that melatonin also inhibits 
Figure 4  Transversal section of the liver of a melatonin-
treated rat shows focal necrosis (at the periphery 
of the lobule). No other pathological changes were 
observed (magniﬁ cation x100).














Figure 2  Transversal section of the liver of a benzene-treated 
rat shows the development of massive necrosis in the 
centrilobular region (magniﬁ cation x100).
DISCUSSION
Melatonin (N-acetyl-5-methoxytryptamine) is an 
indolamine known to be involved in the biochemical 
regulation of the circadian rhythm and other biological 
functions (30, 31). It is also synthesised in extra 
pineal sites such as retina, Harderian glands, gut, 
ovary, testes, bone marrow, lens, and skin (32, 33). 
In mammals, melatonin is metabolised either directly 
Figure 3  Transversal section of the liver of a melatonin and 
benzene-treated rat shows no centrilobular necrosis. 
However, high mitotic activity was observed. The 
number of Kupffer cells was increased (magniﬁ cation 
x100).
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benzene-induced lipid peroxidation. All doses of 
melatonin administered to benzene-treated rats were 
found to attenuate the increase in thiobarbituric acid 
reactive substances (TBARS) concentrations observed 
at progressing stages of liver injury. However, 
the highest protection was recorded after 24 h of 
treatment. Our observations have been supported by 
an earlier study by Ohta et al. (15) on the preventive 
effect of melatonin on the progression of alpha-
naphthylsocyanate-induced acute liver injury in rats.
Melatonin is ﬁ ve times superior to glutathione 
in scavenging free hydroxyl radicals. Both methoxy 
group at position 5 of the indole nucleus and the acetyl 
group of the side chain of melatonin are essential 
to scavenge free hydroxyl radicals (10). Melatonin 
donates an electron to scavenge OH and becomes 
indolyl cation radical, which in turn neutralises 
superoxide radical (39).
To verify the decrease in lipid peroxidation 
manifested by melatonin in benzene-treated rats, we 
measured GSH. An earlier report from our laboratory 
showed that circadian rhythms influenced GSH 
status in the liver of benzene-treated rats (22). GSH 
levels were lower in rats administered benzene in 
the morning than in the evening. In the present study 
melatonin administered in the morning improved the 
GSH status in the liver of benzene-treated rats. There 
are reports that pharmacological doses of melatonin 
given orally to alpha-naphthylisothiocyanate- and 
N-acetyl-para-aminophenol (APAP)-treated rats did 
not affect GSH levels in acute liver injury (15, 16). 
In contrast, other reports indicate beneﬁ cial effects 
of melatonin on arsenic-induced oxidative stress in 
the liver and kidney of Wistar rats (18). It was shown 
recently that expression of genes responsible for 
oxidative stress and detoxiﬁ cation enzymes is altered 
by benzene in mice (40). Genes corresponding to the 
circadian rhythm were also affected by benzene (40). 
Several reports have conﬁ rmed that antioxidative 
effects of melatonin are caused by at least two different 
mechanisms, which might, however, be interdependent 
(41). It has been demonstrated that the glutathione-
glutathione peroxidase system suppresses hydroxyl 
radical generation and prevents oxidative damage and 
destruction due to this highly reactive radical (42). Our 
results are supported by these observations.
Our present results show that acute exposure to 
benzene signiﬁ cantly increased CYP
450
2E1 activity in 
the liver. Circadian effect of benzene on CYP
450
2E1 
has also been demonstrated (22). Although circadian 
time structure of the CYP
450
2E1 system and of its 
different isozymes has been well described (43), 
the effect of melatonin on CYP
450
2E1 after benzene 
exposure is still unknown. Benzene is chiefly 
metabolised into phenol, which is excreted in urine. 
In our earlier study (22), urine phenol in benzene-
treated rats was higher in the evening group than in the 
morning group, showing an inverse relationship with 
CYP
450
2E1, that was higher in the morning than in the 
evening group. This suggests that CYP
450
2E1 activity 
varies with melatonin concentration. Semak et al. (44) 
believe that microsomal CYP
450
2E1 plays a smaller 
role in melatonin-O-demethylation in rat liver. Both 
endogenous and administered melatonin are known to 
metabolise in humans principally by 6-hydroxylation, 
with O-demethylation representing a relatively 
minor pathway. The resulting 6-hydroxymelatonin 
(6-HMEL) and N-acetyl-5-hydroxytrypamine (N-
acetylseratonin) are excreted in urine as their sulphate 
and glucuronide conjugates (45).
Semak  e t  a l .  ( 44 )  demons t r a t ed  t ha t
2-hydroxymelatonin and AFMK were also formed in 
reactions catalysed by the liver CYP
450
. They showed 
that mitochondrial CYP
450
 participated in melatonin 
metabolism in rat liver. They identiﬁ ed mitochondria 
as the target of melatonin reactions.
Melatonin increases the activity of the respiratory 
chain complexes I and IV, inhibits mitochondrial 
pathways of apoptosis, and participates in the circadian 
oscillations of oxidative phosphorylation (46, 47). 
Metabolic pathways of melatonin in microsomes 
and mitochondria involve the same CYPs. At least in 
rats, CYP
450
2E1 additionally contributes to melatonin 
metabolism in the mitochondria. We believe that 
melatonin expresses antioxidative effects against 
benzene by accelerating its metabolism through 
CYP
450
2E1 and GSH concentrations in the liver. 
Histopathological ﬁ ndings are in agreement with 
other observations and support this conclusion. This 
does not undermine the free radical scavenging 
character of melatonin, but offers an explanation 
for CYP
450
2E1-mediated protection against benzene 
toxicity. The absence of prominent lesions in the 
liver of melatonin-treated rats exposed to benzene 
only conﬁ rms melatonin’s antioxidative effects. Our 
ﬁ ndings may be relevant for occupational health.
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Sažetak
MELATONIN INHIBIRA LIPIDNU PEROKSIDACIJU U JETRI ŠTAKORA UZROKOVANU 
BENZENOM
Istražena je antioksidacijska uloga melatonina u zaštiti protiv toksičnoga djelovanja benzena u jetri štakora. 
Utvrđeno je da kratkoročno odnosno dugoročnije liječenje štakora melatoninom u različitoj mjeri štiti štakore 
istodobno izložene benzenu. Inhibicija lipidne peroksidacije mitohondrija i mikrosoma bila je različita nakon 
24 h, 15 dana, odnosno 30 dana liječenja melatoninom. Najveća inhibicija lipidne peroksidacije mitohondrija 
zamijećena je nakon primjene jednokratne doze melatonina, dok je najizraženija inhibicija u mikrosomima 
zamijećena nakon 30 dana liječenja melatoninom. Slična istraživanja pokazuju da razina glutationa (GSH) 
najviše raste nakon 24 h liječenja melatoninom. Nije zamijećena razlika između liječenja u trajanju od 
15 odnosno 30 dana. U štakora koji su uz benzen istodobno primali i melatonin razine citokroma P
450
2E1 
pale su nakon 24 h odnosno 15 dana izloženosti. U štakora koji su primali samo melatonin te su razine 
nakon 30 dana statistički neznačajno porasle u odnosu na skupinu izloženu samo benzenu. Histopatološka 
analiza jetre načelno je potvrdila ove nalaze. Koncentracije fenola u mokraći bile su niže u štakora koji su 
istodobno primali melatonin i benzen. Ovi rezultati pokazuju da melatonin utječe na citokrom P
450
2E1, koji 
je odgovoran za metabolizam benzena. Inhibira li se njegov metabolizam, smanjuje se lipidna peroksidacija. 
Zaključak je da melatonin štiti od lipidne peroksidacije uzrokovane benzenom.
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